Leah Kuntz

If you missed out on the custom Around the Practice video program on naloxone, we've got you covered. Read a recap here.

A recent study examined hyperprolactinemia and antipsychotic therapy in patients with schizophrenia and Hashimoto's thyroiditis.

The FDA has approved dexmedetomidine sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

Individuals with depression may be at a greater risk to develop late-onset Alzheimer disease, but a new study suggests depression onset may help predict Alzheimer disease.

What US state has the best mental health care?

Today is World Bipolar Day! Celebrate with the freshest clinical pearls on bipolar disorder that Psychiatric Times has to offer.

Patients with bipolar I disorder and other mental illnesses may be at increased risk for COVID-19 infection.

Two forms of telehealth can improve quality of life and care for patients with PTSD and bipolar disorder who live in more rural communities.

This donepezil transdermal system helps with the treatment on mild, moderate, or severe dementia of the Alzheimer type.

Is the mental health of young athletes in danger?

Catch up on all the latest in psychiatric comorbidities.

TikTok: How is it harming child and adolescent mental health?

Can a game improve children and adolescents knowledge of the opioid crisis?

According to this study examining sexual minority patients, depression can be a consequence of health and behavioral disparities.

The Chief Medical Officer for the AFSP sat down with Psychiatric Times to talk about the new Blueprint for Youth Suicide Prevention.

TikTok has over 1 billion users and dominates youth culture. But is it damaging their mental health?

Are lower vitamin D levels in women related to depressive mood?

The mental health of Ukrainians is essential, now more than ever.

What woman inspires you?

Investigators have launched a 3-year study to develop predictive models that will help identify better treatment plans for patients with depression.

Digital therapeutics may be poised to step up as the next CBT.

Catch up on all the latest in ADHD from the APSARD virtual 2022 Annual Meeting.

For American Heart Month, catch up on all the latest in psychocardiology.

A new study showed zuranolone treatment in patients with major depressive disorder demonstrates a rapid and statistically significant reduction in depressive symptoms.

The conversation on the Goldwater Rule is taking place now. Don't miss out on the latest in the debate.

Petros Levounis, MD, MA, has been chosen to lead the APA by his fellow members.

Alkermes announced positive results from their phase 3b ENLIGHTEN-Early study.

Sleep, depression, and bipolar disorder: what's the connection?

Effective treatment of depression in individuals with comorbid depression and type 2 diabetes mellitus is important for both conditions.

Physician-assisted suicide: the debate continues.